Paloma Partners Management CO Novartis Ag Transaction History

Paloma Partners Management CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $217,738 - $246,305	-2,718 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $216,624 - $239,537	2,718 New	2,718 $238,000
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $487,572 - $567,224	-5,962 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $508,200 - $561,322	5,962 New	5,962 $544,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $512,940 - $604,901	-6,143 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $479,584 - $580,083	6,143 New	6,143 $580,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $654,724 - $740,261	-7,762 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $475,260 - $523,708	5,556 Added 251.86%	7,762 $675,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $3.16 Million - $3.89 Million	-41,961 Reduced 95.01%	2,206 $201,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $3.33 Million - $3.8 Million	44,167 New	44,167 $4.25 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.